ArticleEuropean journal of medical research2025
Surgical treatment of rib fractures more than one month after injury: a single-center experience.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perioperative ultrasonography in surgical stabilization of rib fractures: A single-center retrospective analysis of its utility in surgical planning and post-discharge follow-up.Turk gogus kalp damar cerrahisi dergisi · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn recent years, surgical stabilization of rib fractures (SSRF) has gained widespread acceptance, with a prevailing consensus that the procedure should be performed as promptly as possible. However, it remains uncertain whether patients with rib fractures sustained for more than one month experience significant benefits from undergoing SSRF. This study primarily investigates the effectiveness and safety of SSRF in patients who have suffered rib fractures for over one month.
methodsA retrospective analysis was performed on the clinical data of patients with rib fractures who were hospitalized between January 2017 and March 2023, specifically those who had sustained injuries for more than one month. All patients included in this study underwent SSRF. The analysis primarily focused on evaluating improvements in chest wall deformity, alleviation of chronic chest pain, and the incidence of postoperative complications following SSRF.
resultsThis cohort consisted of 22 cases, among which 16 patients underwent SSRF within 1-3 months following their injuries, while the remaining 6 patients had SSRF performed after a period exceeding 3 months. In the early intervention group (1-3 months), comprising 16 patients, 12 (75%) presented with chest wall deformities, all of which demonstrated significant improvement postoperatively. The average preoperative pain score was recorded at 7.31 ± 0.68, in contrast to a postoperative score of 1.25 ± 0.43 (p < 0.05). Post-surgical complications included one case of chest wall numbness and another reporting a foreign body sensation in the chest wall. In the group consisting of 6 patients who underwent surgery more than 3 months post-injury, all demonstrated significant improvement in chest wall deformities following SSRF. The average preoperative pain score for this group was recorded at 5.17 ± 1.46, while the postoperative score indicated a notable reduction to 1.33 ± 0.47 (p < 0.05).
conclusionsFor patients with rib fractures who have not undergone SSRF within one month and continue to experience significant pain and/or chest wall deformities, it is recommended to consider a minimally invasive SSRF procedure via a small incision. This approach can improve the correction of chest wall deformity, alleviate chronic chest pain, and is associated with minimal postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.